Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth M Ruprecht

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
AIDS (London, England)|August 28, 2007
Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challengesRobert A Rasmussen, Helena Ong, Ruijiang Song, et al.
Journal of Immune Based Therapies and Vaccines|January 20, 2011
Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIVJames B Whitney, Saied Mirshahidi, So-Yon Lim, et al.
Virology|July 2, 2003
Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispeciesMarjorie Pion, Giselle Sanchez, Vladimir Liska, et al.
Vaccine|January 13, 2006
DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in miceRobert A Rasmussen, Helena Ong, Christian Kittel, et al.
The Journal of Infectious Diseases|January 1, 2004
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccineFlavia Ferrantelli, Moiz Kitabwalla, Robert A Rasmussen, et al.
The Journal of Infectious Diseases|June 8, 2004
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodiesFlavia Ferrantelli, Robert A Rasmussen, Kathleen A Buckley, et al.
Plos One|March 5, 2020
Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaquesKonstantin Virnik, Margherita Rosati, Alexei Medvedev, et al.
Journal of Medical Primatology|November 4, 2010
Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxisNagadenahalli B Siddappa, Girish Hemashettar, Yin Ling Wong, et al.
Frontiers in Immunology|August 20, 2021
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV ChallengesSiqi Gong, Samir K Lakhashe, Dinesh Hariraju, et al.
Vaccine|September 15, 2007
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeysShisong Jiang, Robert A Rasmussen, Katrina M Nolan, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
AIDS (London, England)|August 28, 2007
Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challengesRobert A Rasmussen, Helena Ong, Ruijiang Song, et al.
Journal of Immune Based Therapies and Vaccines|January 20, 2011
Prior exposure to an attenuated Listeria vaccine does not reduce immunogenicity: pre-clinical assessment of the efficacy of a Listeria vaccine in the induction of immune responses against HIVJames B Whitney, Saied Mirshahidi, So-Yon Lim, et al.
Virology|July 2, 2003
Truncated forms of human and simian immunodeficiency virus in infected individuals and rhesus macaques are unique or rare quasispeciesMarjorie Pion, Giselle Sanchez, Vladimir Liska, et al.
Vaccine|January 13, 2006
DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in miceRobert A Rasmussen, Helena Ong, Christian Kittel, et al.
The Journal of Infectious Diseases|January 1, 2004
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccineFlavia Ferrantelli, Moiz Kitabwalla, Robert A Rasmussen, et al.
The Journal of Infectious Diseases|June 8, 2004
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodiesFlavia Ferrantelli, Robert A Rasmussen, Kathleen A Buckley, et al.
Plos One|March 5, 2020
Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaquesKonstantin Virnik, Margherita Rosati, Alexei Medvedev, et al.
Journal of Medical Primatology|November 4, 2010
Development of a tier 1 R5 clade C simian-human immunodeficiency virus as a tool to test neutralizing antibody-based immunoprophylaxisNagadenahalli B Siddappa, Girish Hemashettar, Yin Ling Wong, et al.
Frontiers in Immunology|August 20, 2021
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV ChallengesSiqi Gong, Samir K Lakhashe, Dinesh Hariraju, et al.
Vaccine|September 15, 2007
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeysShisong Jiang, Robert A Rasmussen, Katrina M Nolan, et al.
Pageof 11